Kasabach Merritt syndrome

From WikiMD.org
Jump to navigation Jump to search

Kasabach-Merritt Syndrome

Kasabach-Merritt Syndrome (pronunciation: kah-suh-bach merr-it sin-drome) is a rare hematologic disorder characterized by the presence of a vascular tumor and a severe coagulopathy resulting from platelet trapping within the tumor. The syndrome was first described by Haig Haigouni Kasabach and Katharine Krom Merritt in 1940.

Etymology

The syndrome is named after the two pediatricians, Haig Haigouni Kasabach and Katharine Krom Merritt, who first described the condition in 1940.

Symptoms

The primary symptoms of Kasabach-Merritt Syndrome include the presence of a rapidly growing vascular tumor, usually present at birth or appearing in the first few weeks of life, and a severe coagulopathy resulting from platelet trapping within the tumor. Other symptoms may include anemia, thrombocytopenia, and disseminated intravascular coagulation.

Diagnosis

Diagnosis of Kasabach-Merritt Syndrome is typically made based on the presence of a rapidly growing vascular tumor and laboratory findings of a severe coagulopathy. Additional diagnostic tests may include ultrasound, magnetic resonance imaging (MRI), and biopsy of the tumor.

Treatment

Treatment of Kasabach-Merritt Syndrome typically involves addressing the underlying vascular tumor and managing the coagulopathy. This may include surgery, radiation therapy, chemotherapy, and/or immunotherapy. In some cases, blood transfusion may be necessary to manage anemia and thrombocytopenia.

See Also

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski